Product Description

ROZ 35 Tablets contain Cyproterone Acetate 2 mg and Ethinylestradiol 0.035 mg, a hormonal combination with antiandrogenic and estrogenic activity.

The formulation is used in selected androgen-dependent conditions in women and also provides contraceptive activity when used according to the approved regimen.

ROZ 35 is supplied as a 10 × 1 × 21 Alu-Alu blister pack containing 210 tablets under the OBIGYN division.

Therapeutic Uses

Cyproterone acetate + ethinylestradiol combinations may be prescribed for selected androgen-dependent conditions in women, depending on the approved indication.

The combination may be used in situations involving manifestations such as:

• Androgen-related acne
• Hirsutism
• Androgen-dependent symptoms

NOTE : Because this is a hormonal prescription medicine, the exact indication and treatment regimen should be determined by a qualified healthcare professional.